INTEGRA's VIAFLO 96 helps improve reproducibility of high content screening

INTEGRA’s VIAFLO 96 electronic multi-channel pipetting system is helping biotechnology company HCS Pharma to improve the reproducibility of high content screening using its patented BIOMIMESYS® 3D cell culture technology.

INTEGRA’s VIAFLO 96 electronic multi-channel pipetting system

 

96-well cell culture plates are not easy to handle, even with multi-channel pipettes. The VIAFLO 96 is really user-friendly, and allows us to, for example, seed cells, dispense reagents or perform media exchanges in every well simultaneously.

This is both extremely convenient – saving the operator a lot of time – and helps to improve the reproducibility of results by allowing more precise manipulation of cultures.

This is particularly important during media exchange, as you need to avoid disturbing the gel. With the VIAFLO 96, you can do this very easily and consistently, without the risk of accidents, making our experiments more reproducible.

The system is very compact, which means that it easily fits under our existing laminar flow hood, which is a real advantage, as the cell cultures remain within a sterile environment for manipulation, which is very important for cell seeding and changing media.

It saves space and is cost-effective compared to a fully automated liquid handling robot – it's a great intermediate between a handheld pipette and a robot."

Elodie Vandenhaute, Study Director at HCS Pharma

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    INTEGRA Biosciences. (2019, June 20). INTEGRA's VIAFLO 96 helps improve reproducibility of high content screening. News-Medical. Retrieved on December 21, 2024 from https://www.news-medical.net/news/20181206/INTEGRAs-VIAFLO-96-helps-improve-reproducibility-of-high-content-screening.aspx.

  • MLA

    INTEGRA Biosciences. "INTEGRA's VIAFLO 96 helps improve reproducibility of high content screening". News-Medical. 21 December 2024. <https://www.news-medical.net/news/20181206/INTEGRAs-VIAFLO-96-helps-improve-reproducibility-of-high-content-screening.aspx>.

  • Chicago

    INTEGRA Biosciences. "INTEGRA's VIAFLO 96 helps improve reproducibility of high content screening". News-Medical. https://www.news-medical.net/news/20181206/INTEGRAs-VIAFLO-96-helps-improve-reproducibility-of-high-content-screening.aspx. (accessed December 21, 2024).

  • Harvard

    INTEGRA Biosciences. 2019. INTEGRA's VIAFLO 96 helps improve reproducibility of high content screening. News-Medical, viewed 21 December 2024, https://www.news-medical.net/news/20181206/INTEGRAs-VIAFLO-96-helps-improve-reproducibility-of-high-content-screening.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
INTEGRA Biosciences announces the appointment of a new board member